A pharmaceutical email list names the directors who own a budget at drug makers, biotech companies, contract manufacturers (CDMOs) and contract research organizations (CROs): clinical operations, regulatory, quality, supply chain, commercial and procurement. Scalelist finds and verifies contact details on demand from one plain-English query, so you describe the people you want and get verified work emails and mobile numbers, which is what gets you past a pharma switchboard.
Each contact needs a verified work email and, if you plan to call, a mobile, because pharma switchboards rarely put you through.
Scalelist does not sell a pre-built pharmaceutical email list; below is how to build one.
Below: how big the audience is, why the lists that rank mix up two industries, which functions buy, a Massachusetts worked example with the cost, and sentences you can paste today.
What is a pharmaceutical email list?
A pharmaceutical email list is a set of named decision makers at companies that discover, develop, make or ship drugs, each with a work email and ideally a mobile. That means drug makers, biotech companies, CDMOs, CROs and drug distributors.
Pharmacies sell those drugs to patients, so they buy different things from different people. The pages that rank for this keyword often blur the two: one ranking page is a pharmacy guide, and seller pages mix pharmacists into “pharma” totals.

Selling to pharmacies instead? Use our pharmacy email list guide: owners, pharmacists in charge and chain buyers. Selling to device makers? See the medical device manufacturers email list.
How many pharmaceutical companies and employees are there in the US?
The US had 355,400 jobs in pharmaceutical and medicine manufacturing in 2025, an annual average from the Bureau of Labor Statistics (BLS CES). The same agency counted 7,786 private pharmaceutical and medicine manufacturing locations in 2025 (BLS QCEW). For contrast, it counted 60,629 pharmacy locations (BLS QCEW, NAICS 456110).
Scalelist’s Lead Finder matches 596,279 US profiles at pharmaceutical manufacturers and 207,796 directors, VPs, heads, executives and founders across pharma and biotech, as of 21 October 2026. Profiles can include past roles, so treat them as upper bounds.

A location is not a company: a large drug maker with five plants counts five times in the BLS figure.
Why do pharmaceutical list sellers disagree by 25 times?
Pharmaceutical list sellers disagree because each one counts a different audience and none shows its method. On 21 October 2026, one ranking page advertised “13K+” pharmaceutical contacts and another “350k+”, about 25 times more. Neither total tells you how many clinical operations directors in your state are in the file, or when each record was checked.
The bigger total usually means a wider net: pharmacists, sales reps and lab staff counted as “pharma”. The smaller one may be cleaner, but you cannot tell until you have paid.
Who buys at a pharmaceutical company?
Six functions make most buying decisions at a pharmaceutical company, and each one needs its own list. Titles are director, VP or head level; below that, people influence but rarely sign.

- Clinical operations runs trials: site management, patient recruitment, trial software, CRO selection. 1,109 US profiles.
- Regulatory affairs owns submissions and documentation: publishing software, writing services, consultants. 1,432 US profiles.
- Quality owns quality systems, audits, lab testing and validation. 3,056 US profiles.
- Supply chain and procurement buys cold-chain logistics, packaging, raw materials and supplier services. 852 US profiles.
- Commercial and marketing buys launch services, market research, agencies and sales tools. 3,782 US profiles.
- Manufacturing and operations at plants and CDMOs buys equipment, maintenance and automation. Our manufacturing email list guide covers plant roles in depth.
Counts are directors and above at US pharma and biotech companies on 21 October 2026, an upper bound.
What should a pharmaceutical email list include?
A pharmaceutical email list needs the usual contact fields plus three that decide relevance: the company type, the function, and the development stage or therapeutic focus.
| Field | Why it matters in pharma | Example (fictional) |
|---|---|---|
| Name and job title | Director who signs, or analyst who researches? | Megan Callahan, Director, Clinical Operations |
| Company | Groups contacts into one buying committee | Harborline Therapeutics |
| Company type | Drug maker, biotech, CDMO, CRO or distributor | Clinical-stage biotech |
| Function | Clinical, regulatory, quality, supply chain, commercial | Clinical operations |
| Company size | A 60-person biotech buys unlike a top-20 drug maker | 51 to 200 employees |
| City and state | Territory and calling hours | Cambridge, Massachusetts (Eastern) |
| Work email and status | Valid, Risky or Not found | Valid |
| Mobile number | Skips the switchboard | +1 555 0136 |
| Date found | When to rebuild | 21 Oct 2026 |
Should you buy a pharmaceutical industry email list or build one?
Build one. A bought pharmaceutical industry email list gives you a headline total, a sample and a price, but no date per record and no way to see how many people match your function and state. Pharma teams also reorganize after mergers, trial readouts and layoffs, so last year’s file ages fast.
ZeroBounce found that at least 23% of the 11 billion email addresses it checked in 2025 had gone bad or could not be confirmed (ZeroBounce, 2026). That is vendor data across all kinds of lists. Our B2B data decay guide explains why it happens.

| Factor | Bought pharma file | Pharma list you build |
|---|---|---|
| Freshness | Compiled before you bought it | Found the week you send |
| Size | A headline total you cannot check | A live count for your sentence, before you pay |
| Audience | Pharmacies and drug makers often mixed | Only the company type and function you sell to |
| Verification | One claim for the whole file | Valid, Risky or Not found per email |
| Mobile numbers | Usually the main line | A mobile for everyone you will call |
For the general case across industries, see B2B email lists: build your own or buy one.
How to build a pharmaceutical email list in Scalelist
You build a pharmaceutical email list in Scalelist by describing the function, the company type and the territory in one sentence, checking the free count, then revealing emails and mobiles for the people who match.
Example: Priya Raman is the founder of TrialPath in Boston, Massachusetts (fictional), which sells trial site-management software. Clinical operations leaders sign, so she types this into Scalelist’s Lead Finder:

Lead Finder reads back the clinical operations titles, pharma and biotech, and Massachusetts, and shows the count for free. On 21 October 2026 it was 104 people.

Every email is verified before it is returned and labeled Valid or Risky. About 20 to 30% of Risky emails turn out to be deliverable, so send those from a secondary domain. Our guide to email verification statuses explains each label.
What one pharma contact costs
Priya calls every lead, so she reveals an email and a mobile for all 104: at most 104 leads + 104 emails + 1,040 for mobiles = 1,248 credits, which fits the Scaler 2K plan. What one full contact (12 credits) costs on each plan:
| Plan | Price per month | Price per credit | One contact with email and mobile |
|---|---|---|---|
| Scaler 2K | 89 USD | 4.45 cents | about 0.53 USD |
| Scaler 5K | 199 USD | 3.98 cents | about 0.48 USD |
| Scaler 10K | 349 USD | 3.49 cents | about 0.42 USD |
| Scaler 20K | 649 USD | 3.25 cents | about 0.39 USD |
A 500-contact pharmaceutical list costs at most 6,000 credits, and nothing is charged for an email or mobile that is not found. All plans are on Scalelist pricing.
Describe the pharma or biotech leaders you sell to in one sentence and see how many match before you pay.
Find your first 20 contactsPharmaceutical segments and sample prompts
Each pharmaceutical segment below needs its own sentence, because each one buys something different. Counts are matching US profiles on 21 October 2026, an upper bound; size the CDMO and CRO sentences in the app.
| Segment | Sentence to type in Lead Finder | Matching profiles |
|---|---|---|
| Commercial leaders | VPs of commercial, marketing and sales and brand directors at US pharma and biotech companies | 3,782 |
| Quality leaders | Directors and VPs of quality at US pharma and biotech companies | 3,056 |
| Regulatory leaders | Directors and VPs of regulatory affairs at US pharma and biotech companies | 1,432 |
| Clinical operations | Directors and VPs of clinical operations at US pharma and biotech companies | 1,109 |
| Supply chain and procurement | Directors of supply chain and procurement at US pharma and biotech companies | 852 |
| CDMO and CRO leaders | Business development and operations directors at US contract manufacturers and contract research organizations | count in app |
Add a state or a hub such as Boston, the San Francisco Bay Area, San Diego, New Jersey or the Research Triangle in North Carolina to get a territory one rep can work end to end.
How to reach pharmaceutical decision makers
Pharma directors answer outreach about a number they are measured on: trial enrollment speed, days to a submission, batch release time, deviations closed, or stock-outs avoided. Name the program stage or the site in the first line, never a generic “life sciences” pitch.
- Write to the function, not the company. A quality director and a commercial VP at the same biotech want different emails.
- Call the mobile. In Nooks’ analysis of nearly 3 million dials, mobile numbers connected 45% more often than other numbers (Nooks, 2025). Our Mobile Finder adds mobiles to a pharma list you already have.
- Stay operational. Talk about workflow, timelines and cost. Leave product claims about drugs and patients out of a cold email.
Hi Megan,
How many weeks does it take Harborline to activate a new trial site today?
TrialPath tracks site start-up tasks in one place for clinical-stage biotechs with 50 to 500 employees. Can I show you what it changed for a Phase 2 sponsor in Cambridge?
Priya Raman
TrialPath, Boston
Is it legal to email and call a pharmaceutical email list?
Rules for business email and sales calls exist and differ by channel and state, so check them before you send or dial: our B2B cold calling laws guide covers them. How Scalelist handles contact data is on the trust center.
Related lists
Pharma sits inside a larger buying market: the healthcare email list guide covers practices, hospitals and care organizations with the same method. The oil and gas email list and mining email list guides apply it to field industries, and every other audience is in our lead list guide.
Example record
Fictional example. One row from a list built this way, with the fields that decide who you contact and how you reach them. Pipeline stage and therapeutic area are not fields in the record, so take them from the company site before you write.
| Name | Job title | Company | Industry | Company size | City and state | Work email | Mobile |
|---|---|---|---|---|---|---|---|
| Megan Callahan | Director, Clinical Operations | Harborline Therapeutics | Clinical-stage biotech | 120 employees | Cambridge, Massachusetts | m.callahan@harborlinetx.com (Valid) | +1 555 0136 |
Build this list in Scalelist
Scalelist’s Lead Finder takes one plain-English sentence. Type the people you want, and it shows what it understood and how many match before you spend a credit.
Clinical operations directors at US biotech companies with 51 to 200 employees in Massachusetts
What comes back: the clinical operations leaders who match, with the company, its type, its size and its city. Each person arrives with a work email that was verified before it was returned and labeled Valid or Risky, and a mobile number for the people you ask for one. Export a CSV, push the contacts to HubSpot, or send them to your sequencer.
Credits are charged on success only: 1 per lead found, 1 per work email found and 10 per mobile found, so a contact with both an email and a mobile is 12 credits. That is about 0.40 USD on the 5,000-credit plan and about 0.32 USD on the 20,000-credit plan. Nothing is charged when nothing is found, and sizing the search costs no credits. Every plan is on Scalelist pricing.
See all B2B email lists for every other audience built the same way.
Build a pharma list with a verified email and a mobile for every director you sell to, and pay only for what is found.
Get 100 credits to test itFAQ
What is the difference between a pharmaceutical email list and a pharmacy email list?
A pharmaceutical email list holds decision makers at drug makers, biotech companies, CDMOs, CROs and distributors. A pharmacy email list holds pharmacy owners, pharmacists in charge and chain buyers. They buy different products, so check which one a seller is offering before you pay, or build the one you need.
How many pharmaceutical companies are there in the US?
The Bureau of Labor Statistics counted 7,786 private pharmaceutical and medicine manufacturing locations in 2025, with 355,400 jobs on average. Locations are sites, not companies: a drug maker with several plants counts once per site. Biotech research firms, CROs and distributors are counted in other categories.
Can you buy a pharmaceutical email list?
Yes, list sellers offer them, but their headline totals differ by about 25 times, often mix pharmacies with drug makers, and rarely show when each record was checked. Building your own from one sentence gives you only the function you sell to, a free live count, and verified emails and mobiles.
Who should be on a pharmaceutical industry email list?
The directors and VPs who sign for what you sell. Trial services go to clinical operations (1,109 US profiles), quality systems to quality leaders (3,056), logistics to supply chain and procurement (852), and launch services to commercial leaders (3,782). Write one Lead Finder sentence per function.
How much does a pharmaceutical email list cost?
With Scalelist, at most 12 credits per contact with a verified email and a mobile: about 0.39 USD at the Scaler 20K rate and about 0.53 USD at Scaler 2K. A 500-contact list costs at most 6,000 credits. Emails and mobiles that are not found cost nothing.
How often should you rebuild a pharmaceutical email list?
Before each campaign. Pharma teams change after mergers, trial results and reorganizations, and directors move between companies. You rebuild from the same sentence, the count is free in the app, and you pay only for the emails and mobiles found.
Sources
- US Bureau of Labor Statistics: CES, All employees, pharmaceutical and medicine manufacturing (series CEU3232540001)
- US Bureau of Labor Statistics: QCEW, Number of Establishments in Private NAICS 3254 Pharmaceutical and medicine manufacturing (series ENUUS0002053254)
- ZeroBounce: The Email List Decay Report for 2026
- Nooks Insights: Here’s who picks up the most (2025)
- US Bureau of Labor Statistics: QCEW, Number of Establishments in Private NAICS 456110 Pharmacies and drug retailers (series ENUUS000205456110)
- Scalelist people counts, 21 October 2026 (matching profiles, United States).
- Google search results for “pharmaceutical email list”, United States, 21 October 2026.